Event Details Home The History of Synthetic Biology Designing Synthetic Biotics Pipeline Our People Leadership Board of Directors Founders and Advisors Investors + Media Company Overview News News Releases In the News Events & Presentations Events Presentations Publications Stock Information Stock Quote & Chart Analyst Coverage Corporate Governance Governance Highlights Management Team Board of Directors Committee Composition Board Diversity Matrix Financials Quarterly Results Investor Resources FAQs Contact IR Email Alerts RSS Feeds Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria Nov 30, 2022 Supporting Materials View Presentation 1.4 MB Investor Resources Contact IR Investor FAQs RSS Feeds Investor Email Alerts Email
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria Nov 30, 2022 Supporting Materials View Presentation 1.4 MB